In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...
Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...
It's time for researchers to reconsider the current paradigm of cancer as a genetic disease, argues Sui Huang from the ...
In a recent essay, scientists challenge the prevailing genetic-focused model of cancer, advocating for a shift towards more ...
Belfast Live on MSN11h
Larne woman's warning to everyone after 'healthy dad's' shock cancer diagnosisA Co Antrim woman is on a mission to raise awareness of lung cancer with a fundraising drive after her dad was recently ...
A rising number of Thais under 50 are being diagnosed with cancer, which a doctor says can be prevented by lifestyle changes ...
I knew I was kind of a guinea pig, but the only other option was staying at home, and I wasn’t going to make it,” Tim Story ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the critical federal funding at risk and what this ...
Seth Wander, MD, PhD, discusses the significance of ESR1 mutations in patients with hormone receptor–positive, HER2-negative ...
Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...
European regulators have cleared Anocca to begin a Phase I/II umbrella trial of its lead targeted T-cell receptor (TCR) therapy ANOC-001 and other pipeline candidates in certain advanced pancreatic ...
In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback